As of 2026-04-03, the Relative Valuation of Cardiff Oncology Inc (CRDF) is (14.66) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.58 USD, the upside of Cardiff Oncology Inc based on Relative Valuation is -1027.6%.
The range of the Relative Valuation is (13.95) - (14.69) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 20.4x - 24.3x | 22.4x |
| Forward P/E multiples | 20.8x - 21.9x | 21.4x |
| Fair Price | (13.95) - (14.69) | (14.66) |
| Upside | -983.0% - -1029.7% | -1027.6% |
| Date | P/E |
| 2026-04-02 | -2.36 |
| 2026-04-01 | -2.40 |
| 2026-03-31 | -2.42 |
| 2026-03-30 | -2.31 |
| 2026-03-27 | -2.31 |
| 2026-03-26 | -2.49 |
| 2026-03-25 | -2.58 |
| 2026-03-24 | -2.58 |
| 2026-03-23 | -2.65 |
| 2026-03-20 | -2.68 |
| 2026-03-19 | -2.71 |
| 2026-03-18 | -2.70 |
| 2026-03-17 | -2.86 |
| 2026-03-16 | -2.83 |
| 2026-03-13 | -2.77 |
| 2026-03-12 | -2.85 |
| 2026-03-11 | -3.00 |
| 2026-03-10 | -3.01 |
| 2026-03-09 | -2.97 |
| 2026-03-06 | -2.80 |
| 2026-03-05 | -2.79 |
| 2026-03-04 | -2.95 |
| 2026-03-03 | -2.82 |
| 2026-03-02 | -2.89 |
| 2026-02-27 | -2.89 |
| 2026-02-26 | -2.92 |
| 2026-02-25 | -2.85 |
| 2026-02-24 | -2.53 |
| 2026-02-23 | -2.33 |
| 2026-02-20 | -2.40 |
| 2026-02-19 | -2.43 |
| 2026-02-18 | -2.33 |
| 2026-02-17 | -2.33 |
| 2026-02-13 | -2.39 |
| 2026-02-12 | -2.36 |
| 2026-02-11 | -2.39 |
| 2026-02-10 | -2.31 |
| 2026-02-09 | -2.36 |
| 2026-02-06 | -2.39 |
| 2026-02-05 | -2.21 |
| 2026-02-04 | -2.36 |
| 2026-02-03 | -2.50 |
| 2026-02-02 | -2.55 |
| 2026-01-30 | -2.61 |
| 2026-01-29 | -2.41 |
| 2026-01-28 | -2.42 |
| 2026-01-27 | -2.98 |
| 2026-01-26 | -4.38 |
| 2026-01-23 | -4.32 |
| 2026-01-22 | -4.43 |